
TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac
TRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac...
Read moreTRADING UPDATES: Motif Bio takeover called off; Yamana buys at Wasamac...
Read moreIN BRIEF: Motif Bio expects market capitalisation of GBP16.2 million...
Read moreTRADING UPDATES: AVI Global sees strong results; Finsbury Food rebound...
Read moreIN BRIEF: Motif Bio 2020 loss narrows due to impairment in prior year...
Read moreIN BRIEF: Motif Bio progresses reverse takeover, expects AIM return...
Read moreLONDON TRADING UPDATES: Motif Bio Says Orange Avenue Buys Subsidiary...
Read moreIN BRIEF: Motif Bio Making Progress On UK Drug Development Firm Buy...
Read moreIN BRIEF: Motif Bio Advancing Process To Complete Reverse Takeover...
Read moreCash Shell Motif Bio Swings To Interim Loss On Derivative Liabilities...
Read moreUK Shareholder Meetings Calendar - Next 7 Days...
Read moreIN BRIEF: Motif Bio Annual Pretax Loss Narrows Amid Takeover Hopes...
Read moreIN BRIEF: Motif Bio Shares Suspended; Still Hopes For Reverse Takeover...
Read more(Sharecast News) - Pharmaceutical company Motif Bio saw its shares suspended from trading on Wednesday in order to satisfy AIM rules....
Read moreCORRECT: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline...
Read moreIN BRIEF: Motif Bio Delays 2019 Results As Faces AIM Takeover Deadline...
Read more